Associate Director/Director, Clinical Imaging

ARTBIO; Cambridge; On-site; GBP 140,000 - 190,000; Full time

Job summary

ARTBIO seeks an Associate Director / Director of Clinical Imaging to lead the imaging and dosimetry strategy for its Radioligand Therapy clinical programs. The role sits as a highly visible member of the Clinical Team, coordinating with program leads and subject matter experts to advance development plans and imaging endpoints.

The successful candidate will guide cross-functional activities across internal teams and external partners, translating scientific insights into strategic clinical

Responsibilities

• Lead imaging and dosimetry strategy for clinical protocols in ARTBIO's Radioligand Therapy programs.
• Manage imaging endpoints and data for multiple trials in collaboration with program leads and SMEs.
• Coordinate cross-functional activities with internal teams and external partners to ensure robust clinical imaging plans.

Job description

Summary

We are seeking an Associate Director / Director of Clinical Imaging who will be expected to take on a highly visible role with internal and external stakeholders through development of the strategy and management of imaging and dosimetry for clinical protocols in ARTBIO's Radioligand Therapy (RLT) clinical development programs. As a critical member of the Clinical Team, you will work closely with program leads, functional heads and subject matter experts to advance the company's development pipeline.

About Us

Channeling Energy. Changing Lives.

ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.

The unique ARTBIO approach

selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for the highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs, with lead program AB001 currently in first-in-human trials. The company is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital.

Cancer is relentless. So are we.

We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration. As an emerging, global biotech with locations in Boston, Basel, London, and Oslo, we take advantage of diverse scientific depth and insights, which makes ARTBIO a unique place to work.

EEO Statement

ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.